We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Zebrafish: A Versatile Animal Model to Study Tumorigenesis Process and Effective Preclinical Drug Screening for Human Cancer Research

    Animal model systems are very important for preclinical evaluation of drugs and also to understand underlined pathophysiology and cellular cross...
    Reference work entry 2023
  2. An animal-free preclinical drug screening platform based on human precision-cut kidney slices

    Objective

    Renal fibrosis is one of the main pathophysiological processes underlying the progression of chronic kidney disease and kidney allograft...

    Henricus A. M. Mutsaers, Michael Schou Jensen, ... Rikke Nørregaard in BMC Research Notes
    Article Open access 20 March 2023
  3. Available Preclinical Tools for Neuroblastoma

    Neuroblastoma is the most predominant and deadly cancer in infants and in young children and contributes significantly to childhood cancer deaths....
    Natarajan Aravindan, Sheeja Aravindan in Handbook of Animal Models and its Uses in Cancer Research
    Reference work entry 2023
  4. Preclinical Models of Meningioma

    The management of clinically aggressive meningiomas remains challenging due to limited treatment options aside from surgical removal and...
    Gerhard Jungwirth, C. Oliver Hanemann, ... Christel Herold-Mende in Biological and Clinical Landscape of Meningiomas
    Chapter 2023
  5. Patient-Derived Xenografts: A Valuable Preclinical Model for Drug Development and Biomarker Discovery

    Patient-derived xenografts (PDXs), established by implanting patient tumor cells into immunodeficient mice, offer a platform for faithfully...
    Teresa Weng, Brendan J. Jenkins, Mohamed I. Saad in Patient-Derived Xenografts
    Protocol 2024
  6. AI-Driven Enhancements in Drug Screening and Optimization

    The greatest challenge in drug discovery remains the high rate of attrition across the different phases of the process, which cost the industry...
    Adam Serghini, Stephanie Portelli, David B. Ascher in Computational Drug Discovery and Design
    Protocol 2024
  7. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development

    In its myriad devastating forms, Tuberculosis (TB) has existed for centuries, and humanity is still affected by it. Mycobacterium tuberculosis ( M....

    Saurabh Chugh, Ritika Kar Bahal, ... Ramandeep Singh in npj Vaccines
    Article Open access 09 March 2024
  8. Prostate Cancer Organoids for Tumor Modeling and Drug Screening

    Prostate cancer (PCa) is the second most common malignancy and the fifth leading cause of cancer death in men worldwide. Despite its prevalence, the...
    Amani Yehya, Fatima Ghamlouche, ... Wassim Abou-Kheir in Cancer Stem Cells
    Protocol 2024
  9. Preclinical models in head and neck squamous cell carcinoma

    Head and neck cancer is the sixth most frequent cancer type. Drug resistance and toxicity are common challenges of the existing therapies, making the...

    Patricia Chaves, María Garrido, ... Antonio Rueda-Domínguez in British Journal of Cancer
    Article Open access 10 February 2023
  10. Zebrafish: A Versatile Animal Model to Study Tumorigenesis Process and Effective Preclinical Drug Screening for Human Cancer Research

    Animal model systems are very important for preclinical evaluation of drugs and also to understand underlined pathophysiology and cellular cross...
    Living reference work entry 2022
  11. Patient-derived tumor models: a suitable tool for preclinical studies on esophageal cancer

    Esophageal cancer (EC) is the tenth most common cancer worldwide and has high morbidity and mortality. Its main subtypes include esophageal squamous...

    Fan Liang, Hongyan Xu, ... Junhe Zhang in Cancer Gene Therapy
    Article 03 August 2023
  12. Resurgence of syphilis: focusing on emerging clinical strategies and preclinical models

    Syphilis, a sexually transmitted disease (STD) caused by Treponema pallidum ( T. pallidum ), has had a worldwide resurgence in recent years and remains...

    Shun ** Liu, ... Feijun Zhao in Journal of Translational Medicine
    Article Open access 18 December 2023
  13. Small cells – big issues: biological implications and preclinical advancements in small cell lung cancer

    Current treatment guidelines refer to small cell lung cancer (SCLC), one of the deadliest human malignancies, as a homogeneous disease. Accordingly,...

    Anna Solta, Büsra Ernhofer, ... Balazs Döme in Molecular Cancer
    Article Open access 24 February 2024
  14. Role of Modeling and Simulation in Preclinical and Clinical Long-Acting Injectable Drug Development

    Innovations in the field of long-acting injectable drug development are increasingly being reported. More advanced in vitro and in vivo ...

    Maxime Siemons, Bram Schroyen, ... Navin Goyal in The AAPS Journal
    Article Open access 17 October 2023
  15. Available Preclinical Tools for Neuroblastoma

    Neuroblastoma is the most predominant and deadly cancer in infants and in young children and contributes significantly to childhood cancer deaths....
    Natarajan Aravindan, Sheeja Aravindan in Handbook of Animal Models and its Uses in Cancer Research
    Living reference work entry 2022
  16. Harnessing preclinical models for the interrogation of ovarian cancer

    Ovarian cancer (OC) is a heterogeneous malignancy with various etiology, histopathology, and biological feature. Despite accumulating understanding...

    Tianyu Qin, Junpeng Fan, ... Chaoyang Sun in Journal of Experimental & Clinical Cancer Research
    Article Open access 16 September 2022
  17. Preclinical Models of Cardiac Disease: A Comprehensive Overview for Clinical Scientists

    For recent decades, cardiac diseases have been the leading cause of death and morbidity worldwide. Despite significant achievements in their...

    Elisa C. H. van Doorn, Jorik H. Amesz, ... Yannick J. H. J. Taverne in Cardiovascular Engineering and Technology
    Article Open access 16 January 2024
  18. Preclinical Studies on Mechanisms Underlying the Protective Effects of Propranolol in Traumatic Brain Injury: A Systematic Review

    Traumatic brain injury (TBI) is a leading cause of mortality and morbidity amongst trauma patients. Its treatment is focused on minimizing...

    James Jae, Yilong Li, ... Ian Ball in Journal of Neuroimmune Pharmacology
    Article 20 June 2024
  19. The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma

    Background

    Advanced gastric cancer (GC) is a lethal malignancy, harboring recurrent alterations in cell cycle pathway, especially the...

    Mei Feng, Hao Xu, ... Yisheng Pan in Journal of Experimental & Clinical Cancer Research
    Article Open access 09 February 2023
  20. Arnicolide D: a multi-targeted anticancer sesquiterpene lactone—preclinical efficacy and mechanistic insights

    Arnicolide D, a potent sesquiterpene lactone from Centipeda minima , has emerged as a promising anticancer candidate, demonstrating significant...

    Shivaprasad Shetty Mangalpady, Sheila I. Peña-Corona, ... Javad Sharifi-Rad in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 23 April 2024
Did you find what you were looking for? Share feedback.